# Cabergoline & Letrozole Versus Letrozole in Ovulation Induction in PCOS

> **NCT07255911** · NA · RECRUITING · sponsor: **Mst.Sumyara Khatun** · enrollment: 72 (estimated)

## Conditions studied

- PCOS

## Interventions

- **DRUG:** Letrozole 0.5mg
- **COMBINATION_PRODUCT:** Cabergoline 0.5 mg

## Key facts

- **NCT ID:** NCT07255911
- **Lead sponsor:** Mst.Sumyara Khatun
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-02-07
- **Primary completion:** 2026-01-06
- **Final completion:** 2026-06-30
- **Target enrollment:** 72 (ESTIMATED)
- **Last updated:** 2025-12-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07255911

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07255911, "Cabergoline & Letrozole Versus Letrozole in Ovulation Induction in PCOS". Retrieved via AI Analytics 2026-06-30 from https://api.ai-analytics.org/clinical/NCT07255911. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*